KOC
NVO

Koss-Olinger Consulting’s Novo Nordisk NVO Stock Holding History

Koss-Olinger Consulting’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,192
Closed -$233K – 205
2022
Q1 		$233K Sell
4,192
-910
-18% -$46.7K 0.04% 167
2021
Q4 		$286K Sell
5,102
-616
-11% -$33.4K 0.04% 159
2021
Q3 		$274K Sell
5,718
-2,980
-34% -$144K 0.04% 185
2021
Q2 		$364K Buy
8,698
+892
+11% +$34.6K 0.05% 170
2021
Q1 		$263K Buy
+7,806
New +$278K 0.04% 185

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Koss-Olinger Consulting's NVO Position: Q2 2022 in Review

Koss-Olinger Consulting sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 4,192 shares — an estimated $233K sold.

Koss-Olinger Consulting first reported a position in NVO in Q1 2021 and held it in 5 quarters. The position peaked at $364K in Q2 2021. 933 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

  • Koss-Olinger Consulting reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
  • Koss-Olinger Consulting sold 4,192 Novo Nordisk shares in Q2 2022, an estimated $233K.
  • Koss-Olinger Consulting first reported a position in Novo Nordisk in Q1 2021 and held it in 5 quarters.
  • Koss-Olinger Consulting's Novo Nordisk position peaked at $364K in Q2 2021.
  • 933 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Koss-Olinger Consulting's 13F filing for Q2 2022, filed 8 Jul 2022.